🔍

CLEAN - Clean Science

📊 NSE: CLEAN 🏢 Chemicals 📅 Last Updated: 12/13/2025 21:06

📢 Recent Corporate Announcements

Clean Science to Discuss Q4 and FY26 Audited Results on May 14, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 29 Apr 2026, 05:27 PM

Clean Science and Technology Limited has scheduled an earnings conference call for Thursday, May 14, 2026, at 4:00 P.M. IST. The management team will discuss the audited financial results for the fourth quarter and the full financial year ended March 31, 2026. Key executives including the Managing Director and CFO will be present to provide insights into the company's performance. This is a routine but essential event for investors to understand the company's growth trajectory and operational efficiency.

Earnings conference call scheduled for May 14, 2026, at 4:00 P.M. IST
Focus on audited financial results for Q4 and FY ended March 31, 2026
Management representation includes MD Siddhartha Sikchi and CFO Sanjay Parnerkar
Universal access dial-in numbers: +91 22 6280 1145 and +91 22 7115 8046

💡 Investors should review the audited financial results once released and participate in the call to gain clarity on margin trends and future guidance.

Clean Science Clarifies Significant Trading Volume Spurt as Market Driven

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 24 Apr 2026, 10:45 AM

Clean Science and Technology Limited has responded to a surveillance query from the National Stock Exchange regarding a recent significant increase in trading volumes. The company stated that there is no undisclosed price-sensitive information or impending corporate actions that would affect the scrip's volume or price. Management clarified that the volume spurt is purely market-driven and outside the company's control. The company remains in compliance with SEBI (LODR) Regulations, 2015, and promises continued transparency.

NSE issued a clarification request on April 23, 2026, regarding high trading volumes
Company confirms zero undisclosed price-sensitive information or pending announcements
Management attributes the volume increase entirely to market-driven factors
Company reaffirmed compliance with SEBI (LODR) Regulations, 2015

💡 This is a standard regulatory response to exchange queries; investors should focus on upcoming earnings or fundamental triggers instead of speculative volume spikes.

Clean Science Updates Authorized Persons for Materiality Disclosures Under SEBI Norms

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 17 Apr 2026, 04:49 PM

Clean Science and Technology Limited has updated its list of Key Managerial Personnel (KMP) authorized to determine the materiality of events for stock exchange disclosures. This update, effective April 17, 2026, is a standard compliance requirement under Regulation 30(5) of the SEBI Listing Regulations. The authorized group includes five senior officials: the Managing Director, Executive Vice-Chairman, CFO, President-Commercials, and Company Secretary. This administrative update ensures the company maintains proper governance channels for timely information sharing with investors.

Board approved the update via circular resolution dated April 17, 2026.
Five key officials, including MD Siddhartha Sikchi and CFO Sanjay Parnerkar, are authorized for materiality assessment.
The update follows previous regulatory intimations dated August 2021, February 2023, and August 2024.
Action ensures compliance with Regulation 30(5) of SEBI (LODR) Regulations, 2015.

💡 This is a routine administrative filing with no impact on the company's financial performance or business strategy. No action is required from investors based on this specific announcement.

Clean Science Invests Rs 50 Crore in Subsidiary Clean Fino-Chem via Rights Issue

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 08 Apr 2026, 05:06 PM

Clean Science and Technology Limited (CSTL) has infused Rs. 50 crore into its wholly owned subsidiary, Clean Fino-Chem Limited (CFCL), by subscribing to 8,36,121 equity shares. The investment was made at a price of Rs. 598 per share, including a premium of Rs. 588. The capital is intended to fund CFCL's ongoing projects in the specialty chemicals sector. CFCL has demonstrated rapid growth, with its turnover increasing from Rs. 1.92 crore in FY24 to Rs. 46.77 crore in FY25.

Investment of Rs. 50,00,00,358 through subscription to a Rights Issue
Acquisition of 8,36,121 equity shares at a premium of Rs. 588 per share
Subsidiary turnover grew significantly from Rs. 1.92 crore (FY24) to Rs. 46.77 crore (FY25)
Funds will be primarily used for project financing within the specialty chemicals segment
CSTL maintains 100% shareholding and control in Clean Fino-Chem Limited

💡 Investors should monitor the scaling of Clean Fino-Chem as it appears to be a high-growth engine for the parent company. The consistent capital infusion suggests aggressive expansion plans in the specialty chemicals space.

Clean Science Re-appoints Promoters; Siddhartha Sikchi Named MD for 5-Year Term

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 01 Apr 2026, 12:34 PM

Clean Science and Technology has formalized its leadership structure for the upcoming term starting April 1, 2026. Mr. Siddhartha Ashok Sikchi, a promoter holding a 5.41% stake, has been appointed as Managing Director for five years. Mr. Krishnakumar Boob (0.20% stake) is re-appointed as Whole-Time Director for five years, while veteran technocrat Mr. Ashok Boob (3.45% stake) will serve as Executive Vice Chairman until July 2027. This move ensures management continuity and leverages the promoters' deep industry expertise of up to 50 years.

Mr. Siddhartha Ashok Sikchi appointed as Managing Director for a 5-year term (2026-2031)
Mr. Krishnakumar Boob re-appointed as Whole-Time Director for a 5-year term (2026-2031)
Mr. Ashok Boob appointed as Executive Vice Chairman with a tenure until July 27, 2027
The three promoter-directors collectively hold approximately 9.06% of the company's equity
Leadership team brings significant experience, including Mr. Ashok Boob's 50 years in chemical engineering

💡 The re-appointment of the core promoter group provides long-term leadership stability and is a positive signal for the company's strategic execution. Investors should remain confident in the management's continuity as they navigate the specialty chemicals market.

Clean Science to Close Trading Window from April 1, 2026, for Q4 FY26 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Mar 2026, 12:29 PM

Clean Science and Technology Limited has announced the closure of its trading window for all designated persons starting April 1, 2026. This closure is a mandatory regulatory requirement under SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the company's financial result declaration. The window will remain closed until 48 hours after the audited financial results for the quarter and year ending March 31, 2026, are announced. The specific date for the board meeting to approve these results will be disclosed at a later time.

Trading window closure for designated persons starts on Wednesday, April 1, 2026.
Closure pertains to the audited financial results for the quarter and fiscal year ending March 31, 2026.
The window will reopen 48 hours after the official declaration of the financial results.
The board meeting date for result approval is yet to be communicated to the exchanges.

💡 This is a routine regulatory filing with no impact on company fundamentals; investors should monitor for the upcoming board meeting date to track Q4 earnings performance.

Clean Science Allots 800 Equity Shares Under ESOS 2021

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 17 Mar 2026, 05:56 PM

Clean Science and Technology Limited has approved the allotment of 800 equity shares to eligible employees under its 2021 Employee Stock Option Scheme. The shares were issued at an exercise price of Rs. 500 per share, which includes a premium of Rs. 499 per share. Following this allotment, the company's total paid-up share capital has increased slightly to Rs. 10,62,77,299. This is a minor administrative update with negligible dilution for existing shareholders.

Allotment of 800 equity shares of face value Re. 1 each to eligible employees
Shares issued at an exercise price of Rs. 500 per share, including Rs. 499 premium
Total paid-up capital increased to Rs. 10,62,77,299 from Rs. 10,62,76,499
Allotment approved by the Nomination and Remuneration Committee via circular resolution on March 17, 2026

💡 No action is required as the equity dilution is extremely minimal. Investors should focus on the company's quarterly earnings and operational performance.

Clean Science Senior VP (R&D) K.R. Lakshmanan Pichaandi Resigns Effective March 14, 2026

🔵 WATCH ⭐ 6/10

MANAGEMENT 📅 16 Mar 2026, 05:59 PM

Clean Science and Technology Limited has announced the resignation of Mr. Kothanda Rama Lakshmanan Pichaandi, the Senior Vice-President of Research and Development. The resignation, cited for personal reasons, became effective at the close of business hours on March 14, 2026. Mr. Pichaandi had submitted his resignation on December 22, 2025, and served a full notice period to ensure a smooth transition. As R&D is a critical function for specialty chemical companies, his departure from the Senior Management Personnel tier is a notable leadership change.

Resignation of Senior VP (R&D) K.R. Lakshmanan Pichaandi effective from March 14, 2026.
The resignation letter was submitted on December 22, 2025, providing a notice period of nearly 3 months.
The company confirmed that all handover responsibilities have been duly completed.
The departure is attributed to personal reasons with no reported operational conflicts.
Mr. Pichaandi was designated as Senior Management Personnel, highlighting his importance to the firm's technical strategy.

💡 Investors should monitor the company's upcoming announcements regarding a successor for the R&D leadership role to ensure continuity in innovation. While the resignation appears routine and planned, the R&D pipeline is vital for the company's long-term competitive advantage.

Clean Science Independent Director Madhu Dubhashi Completes Tenure on Feb 19, 2026

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 19 Feb 2026, 06:42 PM

Clean Science and Technology Limited has announced that Ms. Madhu Dubhashi has completed her term as a Non-Executive Independent Director. Her cessation from the board was effective from the close of business hours on February 19, 2026. This change is a routine transition following the completion of her scheduled tenure as per SEBI regulations. The company has formally acknowledged her contributions and guidance during her association with the board.

Ms. Madhu Dubhashi (DIN: 00036846) ceased to be an Independent Director effective February 19, 2026.
The cessation is due to the completion of her official term and not a resignation.
The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations.
The board and management placed on record their appreciation for her contributions during her tenure.

💡 No action is required as this is a routine board transition. Investors should monitor for future appointments to ensure the board maintains its required independent composition.

Clean Science Independent Director Prof. Ganapati Yadav Completes Tenure on Feb 5, 2026

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 07 Feb 2026, 05:35 PM

Clean Science and Technology Limited has announced that Prof. Ganapati Dadasaheb Yadav has completed his term as a Non-Executive Independent Director. The cessation was effective from the close of business hours on February 5, 2026. This is a routine regulatory disclosure following the completion of a scheduled board term. The company has formally acknowledged his contributions and guidance provided during his tenure.

Prof. Ganapati Dadasaheb Yadav (DIN: 02235661) completed his term as a Non-Executive Independent Director.
The cessation of his role was effective from the end of business hours on February 5, 2026.
The disclosure was made in compliance with Regulation 30 of the SEBI Listing Regulations.
The company has placed on record its appreciation for his valuable contributions during his association.

💡 This is a routine administrative update and does not impact the company's fundamentals. No immediate action is required from investors.

Clean Science Q3 FY26 PAT Declines 13.6% YoY to ₹54.1 Cr; ₹2 Interim Dividend Declared

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 05 Feb 2026, 05:17 PM

Clean Science and Technology Limited reported a consolidated revenue of ₹2,163.6 million for Q3 FY26, marking an 11.5% growth YoY but an 8.2% decline sequentially. Net profit for the quarter fell to ₹541.2 million, down from ₹626.4 million in the previous year, reflecting margin pressure. The company declared an interim dividend of ₹2 per share (200%) with a record date of February 5, 2026. The results indicate a challenging quarter with both YoY and QoQ profit contraction despite higher annual revenue.

Consolidated Revenue from operations stood at ₹2,163.6 million, up 11.5% YoY but down 8.2% QoQ.
Consolidated Net Profit (PAT) decreased by 13.6% YoY to ₹541.2 million.
Interim Dividend of ₹2 per equity share (200% of face value) declared for FY 2025-26.
Basic EPS for the quarter fell to ₹5.09 from ₹5.90 in the corresponding quarter of the previous year.
Total expenses for the quarter were ₹1,438.2 million, showing significant pressure on operating margins compared to the previous year.

💡 Investors should be cautious due to the sequential and year-on-year decline in profitability and margin compression. Monitor management commentary regarding raw material costs and demand outlook in the specialty chemicals segment.

Clean Science Q3 FY26: Revenue Declines 21% Y-o-Y Amid Pricing Pressure; HALS Business Grows 55%

🔴 NEGATIVE ⭐ 8/10

EARNINGS 📅 04 Feb 2026, 11:21 AM

Clean Science reported a challenging Q3 FY26 with consolidated revenue declining 10% sequentially to INR 216 crores and a 21% Y-o-Y drop in sales. The performance was hit by pricing pressure from Chinese competitors in the MEHQ segment and the loss of a key FMCG customer for 4-MAP due to backward integration. However, the HALS business showed strong momentum with 55% Y-o-Y growth and achieved EBITDA breakeven in its subsidiary, Clean Fino Chem. The company also commercialized its new hydroquinone and catechol plant in December, which is expected to improve margins for downstream products like TBHQ.

Consolidated revenue moderated by 10% Q-o-Q to INR 216 crores with PAT margins at 21% and EBITDA at INR 72 crores.
HALS business delivered robust 55% Y-o-Y growth and achieved EBITDA breakeven in the subsidiary Clean Fino Chem Limited.
9-month revenue declined 10% Y-o-Y to INR 602 crores, attributed to pricing pressure and lower offtake in the Agchem segment.
Commercialized hydroquinone and catechol plant in Dec 2025; Performance Chemical 2 capex on track for Q1 FY27.
Board approved an interim dividend of INR 2 per share and welcomed two new independent directors.

💡 Investors should monitor the ramp-up of the HALS segment and the margin recovery from the new hydroquinone plant to offset pricing pressures in core products. While the HALS breakeven is positive, the loss of a key FMCG customer and Chinese competition remain significant near-term headwinds.

Clean Science and Technology Releases Q3 FY26 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 31 Jan 2026, 06:59 PM

Clean Science and Technology Limited has submitted the audio recording of its Q3 FY26 earnings conference call held on January 31, 2026. This filing is a routine compliance requirement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The recording provides investors and analysts with access to the management's discussion on the company's financial performance and future outlook. The link to the audio file is available on the company's official website for public review.

Earnings conference call for Q3 FY26 conducted on January 31, 2026
Audio recording made available to the public via the company's website
Compliance with SEBI (LODR) Regulations regarding timely disclosure of investor meets
Provides transparency into management's commentary on quarterly business operations

💡 Investors should listen to the recording to understand management's perspective on margin trends and demand outlook in the specialty chemicals segment.

Clean Science Declares ₹2 Interim Dividend; Q3 Revenue Grows 12% YoY to ₹218.5 Cr

🟡 NEUTRAL ⭐ 8/10

EARNINGS 📅 31 Jan 2026, 02:38 PM

Clean Science and Technology reported a 12.2% YoY growth in consolidated revenue from operations, reaching ₹2,185.5 million for Q3 FY26. However, consolidated net profit saw a decline of approximately 11% YoY, coming in at ₹459.3 million compared to ₹516.1 million in the same quarter last year. The Board has declared an interim dividend of ₹2 per share (200% of face value) with a record date of February 6, 2026. The decline in profit despite revenue growth suggests pressure on margins or increased operational costs during the period.

Consolidated Revenue from Operations grew 12.2% YoY to ₹2,185.5 million in Q3 FY26.
Consolidated Net Profit decreased by 11% YoY to ₹459.3 million from ₹516.1 million.
Declared an interim dividend of ₹2 per equity share (200% on face value of ₹1).
Record date for dividend eligibility is February 6, 2026, with payment by February 23, 2026.
Consolidated EPS for the quarter declined to ₹4.32 from ₹4.86 in the year-ago period.

💡 Investors should monitor the margin compression as net profit fell despite double-digit revenue growth. While the dividend provides a yield, the bottom-line performance suggests rising input or operational costs that need further investigation.

Clean Science Declares ₹2 Interim Dividend; Q3 PAT Declines to ₹45.8 Crore

🟡 NEUTRAL ⭐ 8/10

DIVIDEND 📅 31 Jan 2026, 02:33 PM

Clean Science and Technology has announced an interim dividend of ₹2 per share (200% of face value) for FY 2025-26, with the record date set for February 6, 2026. The company's consolidated revenue for Q3 FY26 stood at ₹249.6 crore, showing growth over the ₹194.7 crore reported in the same quarter last year. However, net profit saw a decline to ₹45.8 crore from ₹56.7 crore YoY and ₹65.7 crore sequentially. The dividend payment is scheduled to be completed by February 23, 2026.

Interim dividend of ₹2 per equity share of face value ₹1 each
Consolidated Revenue from operations at ₹2,496.4 million for Q3 FY26
Consolidated Net Profit (PAT) fell to ₹458.3 million vs ₹567.5 million YoY
Basic EPS for the quarter decreased to ₹4.32 from ₹5.35 YoY
Record date for dividend eligibility is February 6, 2026

💡 Investors seeking the dividend must hold shares before the February 6 record date. While the dividend is a positive payout, the sequential and year-on-year decline in profitability suggests monitoring margin pressures in the specialty chemicals segment.

View All CLEAN Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 16.8% to INR 922.3 Cr in FY25 from INR 789.4 Cr in FY24. By H1 FY26, Performance Chemicals increased its share to 75% (up from 70% in H1 FY25), Pharma & Agro Intermediates contributed 16% (down from 17%), and FMCG Chemicals contributed 9% (down from 13%).

Geographic Revenue Split

As of H1 FY26, the revenue split is: China 38% (up from 36% YoY), Americas 20% (down from 21%), India 19% (up from 17%), Europe 14% (down from 16%), and Rest of World 9% (down from 10%).

Profitability Margins

Net Profit Margin improved to 32.3% in FY25 from 31.8% in FY24, driven by higher sales volumes. Gross margins in the subsidiary are targeted at 35-40%, though they fluctuated to 26% in Q2 FY26 due to inventory accounting (change in stock optics).

EBITDA Margin

EBITDA margin stood at 44% in FY25 (INR 399.1 Cr), a slight increase from 43.4% in FY24 (INR 337.2 Cr). The margin is supported by integrated operations but faces pressure from the ramp-up of new products and raw material volatility.

Capital Expenditure

The company incurred INR 235 Cr capex in FY24 (including INR 215 Cr in subsidiaries). Planned capex for FY26 is approximately INR 300 Cr, focused on the performance chemicals segment and funded entirely through internal accruals and surplus liquidity.

Credit Rating & Borrowing

CRISIL AA-/Stable for long-term and CRISIL A1+ for short-term. The company is debt-free with no long-term borrowing costs; interest coverage ratio improved to 493x in FY25 from 282x in FY24.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Phenol (used to produce Anisole, MEHQ, and BHA) and various crude oil derivatives. Raw material expenses accounted for 40.1% of revenue in Q2 FY26 on a consolidated basis.

Import Sources

Not explicitly disclosed by country, but the company utilizes a mix of local and foreign currency transactions to manage its 60-65% export exposure.

Capacity Expansion

Unit 4, a 34-acre (1,32,700 sq. mtrs) facility for HALS, was commercialized in March 2024. Future expansion includes a INR 300 Cr investment in performance chemicals for FY26.

Raw Material Costs

Raw material expenses were INR 325.8 Cr in FY25, representing 35.3% of total revenue. Costs are sensitive to crude oil fluctuations, with a pass-through mechanism that operates with a time lag.

Manufacturing Efficiency

Efficiency is driven by 'Clean Technology' and integrated operations where Phenol is converted into multiple value-added products like MEHQ and BHA, maintaining operating margins above 40%.

Logistics & Distribution

The company uses a hybrid model of direct sales to large accounts and a distributor network for broader market reach in India and international markets.

📈 Strategic Growth

Expected Growth Rate

25%

Growth Strategy

Growth is targeted through the ramp-up of the HALS (Hindered Amine Light Stabilizers) series (770, 944, 119), adding new chemistries and process technologies, and executing greenfield capex (INR 300 Cr in FY26) to diversify the performance chemicals basket.

Products & Services

Specialty chemicals including Monomethyl Ether of Hydroquinone (MEHQ), Guaiacol, Butylated Hydroxyanisole (BHA), 4-Methoxy Acetophenone (4-MAP), and HALS series (770, 944, 119).

Brand Portfolio

Clean Science and Technology Limited (CSTL), Clean Fino Chem Ltd (Subsidiary).

New Products/Services

Recent launches include higher grades of HALS (944 and 119) which offer better realizations and contributed to a 34% value growth in the HALS portfolio in recent quarters.

Market Expansion

Expansion is focused on increasing direct sales to large global accounts and diversifying the product basket to reduce dependence on core products like MEHQ.

Market Share & Ranking

CSTL is a leading global player in MEHQ, Guaiacol, BHA, and 4-MAP.

Strategic Alliances

Collaborations with academic institutions and industry experts are used to enhance technological capabilities and prevent obsolescence.

🌍 External Factors

Industry Trends

The specialty chemicals industry is shifting toward 'clean' and sustainable manufacturing. CSTL is positioned as a leader in catalytic chemistry, which reduces waste and improves cost-efficiency compared to traditional methods.

Competitive Landscape

Operates in a highly competitive industry requiring constant technological upgrades. Competitors are not named, but CSTL focuses on niche products where it can maintain a dominant global position.

Competitive Moat

Moat is built on proprietary catalytic processes and integrated manufacturing (Phenol to BHA), which are difficult to replicate and provide a significant cost advantage. This is sustained by continuous R&D and a debt-free balance sheet.

Macro Economic Sensitivity

Highly sensitive to global crude oil prices and international trade policies, as 60-65% of revenue is derived from exports.

Consumer Behavior

Increased demand for stabilizers in polymer and plastic industries is driving the growth of the HALS segment.

Geopolitical Risks

Exposure to 35+ countries makes CSTL vulnerable to trade barriers and geopolitical shifts, specifically mentioned is the monitorable impact of US tariff hikes.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to environmental pollution norms and international manufacturing standards for specialty chemicals used in pharma and food (BHA).

Environmental Compliance

The company focuses on 'Clean Technology' to ensure regulatory compliance and operational efficiency, though specific ESG spend in INR is not disclosed.

Taxation Policy Impact

Tax expenses for FY25 were INR 98.2 Cr. The subsidiary Clean Fino Chem Ltd benefits from tax incentives related to its location in the Kurkumbh Industrial Area.

⚠️ Risk Analysis

Key Uncertainties

Volatility in raw material prices (crude derivatives) and sharp fluctuations in foreign exchange rates could impact margins by more than 5% if pass-throughs are delayed.